Eritadenine

Source: Wikipedia, the free encyclopedia.
Eritadenine
Names
Preferred IUPAC name
(2R,3R)-4-(6-Amino-9H-purin-9-yl)-2,3-dihydroxybutanoic acid
Other names
Lentysine; Lentinacin
Identifiers
3D model (
JSmol
)
ChemSpider
UNII
  • InChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
    Key: LIEMBEWXEZJEEZ-INEUFUBQSA-N
  • InChI=1/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
    Key: LIEMBEWXEZJEEZ-INEUFUBQBZ
  • c1nc(c2c(n1)n(cn2)C[C@H]([C@H](C(=O)O)O)O)N
Properties
C9H11N5O4
Molar mass 253.218 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Eritadenine is a chemical compound found in

S-adenosyl-L-homocysteine hydrolase (SAHH) and has hypocholesterolemic activity.[1]

Synthesis

The structure is a purine alkylated with an oxidized sugar fragment.

Eritadenine synthesis:[2] Alternative synthesis:[3]

Ring opening of the protected lactone (1), derived from erythrose with sodium phthalimide gives the acid 2; hydrazinolysis (cf Gabriel synthesis) then leads to the amino acid 3. Displacement of chlorine in pyrimidine 4 by the amine function on 3 serves to attach the future imidazole nitrogen and the sugar-derived sidechain (5). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with formic acid. These strongly acidic conditions serve to remove the acetonide protecting group as well (6). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine (7)

References

  1. ^ "NCATS Inxight: Drugs — ERITADENINE". drugs.ncats.io. Retrieved 2020-01-22.
  2. .
  3. .

External links